Essa Pharma, Inc.
Records under this name other than the patents Essa Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 3 of 3 · Back to Essa Pharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,059,795 | Androgen Receptor Modulators and Methods for Their Use Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,358,938 | Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof Lapsed on the fee record Ended Jun 14, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 14, 2026 | From the USPTO record |
| US 11,242,324 | Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof Lapsed on the fee record Ended Feb 8, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 8, 2026 | From the USPTO record |